Management of CAH during pregnancy: Optimizing outcomes

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 19, Issue 6, 2012, Pages 489-496

  Witchel, Selma Feldman ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

congenital adrenal hyperplasia; CYP21A2; infertility; pregnancy; prenatal treatment

Indexed keywords

CLOMIFENE; DEXAMETHASONE; GESTAGEN; HUMAN MENOPAUSAL GONADOTROPIN; HYDROCORTISONE SODIUM SUCCINATE; PREDNISOLONE; PROGESTERONE;

ANOVULATION; AUTOSOMAL RECESSIVE DISORDER; CONCEPTION; CONGENITAL ADRENAL HYPERPLASIA; DELIVERY; DISEASE ASSOCIATION; FEMALE FERTILITY; FEMALE SUBFERTILITY; FERTILIZATION IN VITRO; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INTRAUTERINE INSEMINATION; LABOR; MALE FERTILITY; NIDATION; NONHUMAN; OLIGOSPERMIA; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY OUTCOME; RECOMMENDED DRUG DOSE; REVIEW; SEX DIFFERENTIATION; STEROID 21 MONOOXYGENASE DEFICIENCY; TESTIS TUMOR; TREATMENT INDICATION; TREATMENT OUTCOME; VIRILIZATION;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ADRENAL REST TUMOR; ADULT; FEMALE; HUMANS; INDIVIDUALIZED MEDICINE; INFANT, NEWBORN; INFERTILITY; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; REPRODUCTIVE HEALTH; REPRODUCTIVE TECHNIQUES, ASSISTED; STEROID 21-HYDROXYLASE;

EID: 84869880835     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e32835a1a2e     Document Type: Review

References (67)

1. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011; 32:81-151.
2. Pang S, Clark A. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: newborn screening and its relationship to the diagnosis and treatment of the disorder. Screening 1993; 2:105.
3. Speiser PW, Dupont B, Rubinstein P, et al. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985; 37:650-667.
4. Witchel SF, Azziz R. Congenital adrenal hyperplasia. J Ped Adolescent Gynecol 2011; 24:116-126.
5. Witchel SF. Nonclassic congenital adrenal hyperplasia. Curr Opin Endocrinol Diabetes Obes 2012; 19:151-158.
6. Pall M, Azziz R, Beires J, Pignatelli D. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia. Fertil Steril 2010; 94:684-689.
7. Bidet M, Bellanné-Chantelot C, Galand-Portier MB, et al. Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members. J Clin Endocrinol Metab 2009; 94:1570-1578.
8. Nandagopal R, Sinaii N, Avila NA, et al. Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families. Eur J Endocrinol 2011; 164:977-984.
9. Stikkelbroeck NM, Hermus AR, Braat DD, Otten BJ. Fertility in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Obstet Gynecol Surv 2003; 58:275-284.
10. Mulaikal RM, Migeon CJ, Rock JA. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 1987; 316:178-182.
11. Krone N, Wachter I, Stefanidou M, et al. Mothers with congenital adrenal hyperplasia and their children: outcome of pregnancy, birth and childhood. Clin Endocrinol (Oxf) 2001; 55:523-529.
12. Kai H, Nose O, Iida Y, et al. Female pseudohermaphroditism caused by maternal congenital adrenal hyperplasia. J Pediatric 1979; 95:418-420.
13. Trakakis E, Dracopoulou-Vabouli M, Dacou-Voutetakis C, et al. Infertility reversed by glucocorticoids and full-term pregnancy in a couple with previously undiagnosed nonclassic congenital adrenal hyperplasia. Fertil Steril 2011; 96:1048-1050.
14. Moran C, Azziz R, Weintrob N, et al. Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. J Clin Endocrinol Metab 2006; 91:3451-3456.
15. Bidet M, Bellanné-Chantelot C, Galand-Portier MB, et al. Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2010; 95:1182-1190.
16. Lo JC, Schwitzgebel VM, Tyrrell JB, et al. Normal female infants born of mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999; 84:930-936.
17. Casteràs A, De Silva P, Rumsby G, Conway GS. Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate. Clin Endocrinol (Oxf) 2009; 70:833-837.
18. Johannsen TH, Ripa CP, Carlsen E, et al. Long-term gynecological outcomes in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Int J Pediatr Endocrinol 2010; 2010:784297.
19. Gastaud F, Bouvattier C, Duranteau L, et al. Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab 2007; 92:1391-1396.
20. Braga LH, Pippi Salle JL. Congenital adrenal hyperplasia: a critical appraisal of the evolution of feminizing genitoplasty and the controversies surrounding gender reassignment. Euro J Pediatr Surg 2009; 19:203-210.
21. Warne G, Grover S, Hutson J, et al. A long-term outcome study of intersex conditions. J Pediatric Endocrinol Metab 2005; 18:555-567.
22. Arlt W, Willis DS, Wild SH, et al. Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J Clin Endocrinol Metab 2010; 95:5110-5121.
23. Stikkelbroeck NM, Beerendonk CC, Willemsen WN, et al. The long term outcome of feminizing genital surgery for congenital adrenal hyperplasia: anatomical, functional and cosmetic outcomes, psychosexual development, and satisfaction in adult female patients. J Pediatr Adolesc Gynecol 2003; 16:289-296.
24. Nordenskjö ld A, Holmdahl G, Frisén L, et al. Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2008; 93:380-386.
25. Nordenström A, Frisén L, Falhammar H, et al. Sexual function and surgical outcome in women with congenital adrenal hyperplasia due to CYP21A2 deficiency: clinical perspective and the patients' perception. J Clin Endocrinol Metab 2010; 95:3633-3640.
26. Meyer-Bahlburg HF, Dolezal C, Baker SW, New MI. Sexual orientation in women with classical or nonclassical congenital adrenal hyperplasia as a function of degree of prenatal androgen excess. Arch Sex Behav 2008; 37:85-99.
27. Sánchez LA, Moran C, Reyna R, et al. Adrenal progestogen and androgen production in 21-hydroxylase-deficient nonclassic adrenal hyperplasia is partially independent of adrenocorticotropic hormone stimulation. Fertil Steril 2002; 77:750-753.
28. Stikkelbroeck NM, Sweep CG, Braat DD, et al. Monitoring of menstrual cycles, ovulation, and adrenal suppression by saliva sampling in female patients with 21-hydroxylase deficiency. Fertil Steril 2003; 80:1030-1036.
29. Levin JH, Carmina E, Lobo RA. Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adultonset congenital adrenal hyperplasia? Fertil Steril 1991; 56:635-640.
30. Carmina E, Lobo R. Ovarian suppression reduces clinical and endocrine expression of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Fertil Steril 1994; 62:738-743.
31. Blank SK, McCartney CR, Helm KD, Marshall JC. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty. Semin Reprod Med 2007; 25:352-359.
32. McGee WK, Bishop CV, Bahar A, et al. Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome. Hum Reprod 2012; 27:531-540.
33. Barnes RB, Rosenfield RL, Ehrmann DA, et al.Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab 1994; 79:1328-1333.
34. Wilson JD, Auchus RJ, Leihy MW, et al. 5a-androstane-3a,17b-diol is formed in tammar wallaby pouch young testes by a pathway involving 5a-pregnane-3a, 17a-diol-20-one as a key intermediate. Endocrinology 2003; 144:575-580.
35. Auchus RJ. The backdoor pathway to dihydrotestosterone. Trends Endocrinol Metab 2004; 15:432-438.
36. Kamrath C, Hochberg Z, Hartmann MF, et al. Increased activation of the alternative 'backdoor' pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis. J Clin Endocrinol Metab 2012; 97:E367-E375.
37. Auchus RJ, Miller WL. Congenital adrenal hyperplasia: more dogma bites the dust. J Clin Endocrinol Metab 2012; 97:772-775.
38. Al-Azemi M, Kyrou D, Kolibianakis EM, et al. Elevated progesterone during ovarian stimulation for IVF. Reprod Biomed Online 2012; 24:381-388.
39. Van Vaerenbergh I, McIntire R, Van Lommel L, et al. Gene expression during successful implantation in a natural cycle. Fertil Steril 2010; 93:268e15-268e18.
40. Patel BG, Lassey BA. Clinical assessment and management of the endometrium in recurrent early pregnancy loss. Semin Reprod Med 2011; 29:491-506.
41. Holmes-Walker DJ, Conway GS, Honour JW, et al. Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 1995; 43:291-296.
42. de Ziegler D, Brioschi PA, Fanchin R, Bulletti C. Confronting the hidden face of progesterone during the follicular phase. J Assist Reprod Genet 2003; 20:29-32.
43. Bosch E, Labarta E, Crespo J, et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod 2010; 25:2092-2100.
44. Check JH, Wilson C, Choe JK, et al. Evidence that high serum progesterone (P) levels on day of human chorionic gonadotropin (hCG) injection have no adverse effect on the embryo itself as determined by pregnancy outcome following embryo transfer using donated eggs. Clin Exp Obstet Gynecol 2010; 37:1791-1880.
45. Labarta E, Mart́nez-Conejero JA, Alamá P, et al. Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod 2011; 26:1813-1825.
46. Kiliçdag EB, Haydardedeoglu B, Cok T, et al. Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles. Arch Gynecol Obstet 2010; 281:747-752.
47. Azem F, Tal G, Lessing JB, et al. Does high serum progesterone level on the day of human chorionic gonadotropin administration affect pregnancy rate after intracytoplasmic sperm injection and embryo transfer? Gynecol Endocrinol 2008; 24:368-372.
48. HofmannGE, Bentzien F, Bergh PA, et al. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril 1993; 60:675-679.
49. Wilkins L, Fleishmann W, Howard JE. Macrogenitosomia precox associated with hyperplasia of the androgenic tissue of the adrenal and death from corticoadrenal insufficiency. Endocrinology 1940; 26:385-395.
50. Stikkelbroeck NM, Otten BJ, Pasic A, et al. High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001; 86:5721-5728.
51. Claahsen-van der Grinten HL, Otten BJ, Sweep FC, et al. Testicular tumors in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency show functional features of adrenocortical tissue. J Clin Endocrinol Metab 2007; 92:3674-3680.
52. Reisch N, Flade L, Scherr M, et al. High prevalence of reduced fecundity in men with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2009; 94:1665-1670.
53. Falhammar H, Nyström HF, Ekström U, et al. Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia. Eur J Endocrinol 2012; 166:441-449.
54. Claahsen-van der Grinten HL, Otten BJ, Takahashi S, et al. Testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia: evaluation of pituitary-gonadal function before and after successful testis-sparing surgery in eight patients. J Clin Endocrinol Metab 2007; 92:612-615.
55. Conway GS. Congenital adrenal hyperplasia: adolescence and transition. Horm Res 2007; 68 (Suppl 5):155-157.
56. Auchus RJ, Witchel SF, Leight KR, et al. Guidelines for the development of comprehensive care centers for congenital adrenal hyperplasia: guidance from the CARES Foundation Initiative. Int J Pediatr Endocrinol 2010; 2010:275213.
57. Auchus RJ. Management of the adult with congenital adrenal hyperplasia. Int J Pediatr Endocrinol 2010; 2010:614107.
58. Nordenström A. Adult women with 21-hydroxylase deficient congenital adrenal hyperplasia, surgical and psychological aspects. Curr Opin Pediatr 2011; 23:436-442.
59. Concolino P, Mello E, Zuppi C, Capoluongo E. Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an update of new CYP21A2 mutations. Clin Chem Lab Med 2010; 48:1057-1062.
60. Merke DP. Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2008; 93:653-660.
61. Clayton PE, Miller WL, Oberfield SE, et al. Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm Res 2002; 58:188-195.
62. Hagenfeldt K, Janson PO, Holmdahl G, et al. Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod 2008; 23:1607-1613.
63. Ogilvie CM, Crouch NS, Rumsby G, et al. Congenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issues. Clin Endocrinol (Oxf) 2006; 64:2-11.
64. Witchel SF, Miller WL. Prenatal treatment of congenital adrenal hyperplasianot standard of care. J Genet Couns 2012. [Epub ahead of print]
65. Poulain M, Frydman N, Duquenne C, et al. Dexamethasone induces germ cell apoptosis in the human fetal ovary. J Clin Endocrinol Metab 2012. doi:10.1210/jc.2012-1681. [Epub ahead of print]
66. Speiser PW, Azziz R, Baskin LS, et al. Endocrine Society. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95:4133-4160.
67. Hirvikoski T, Nordenstrom A, Wedell A, et al. Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: The Swedish experience and standpoint. J Clin Endocrinol Metab 2012; 87:1881-1883.